Serpendipity: Enhanced antithrombotic activity of a novel recombinant heparin cofactor II.

被引：0
|
作者：
Bauman, SJ [1 ]
Church, FC [1 ]
机构：
[1] Univ N Carolina, Sch Med, Chapel Hill, NC USA
来源：
BLOOD | 1998年 / 92卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3380
引用
收藏
页码：92B / 93B
页数：2
相关论文
共 50 条
  • [21] CHARACTERISTICS OF THE CHEMOTACTIC ACTIVITY OF HEPARIN COFACTOR-II PROTEOLYSIS PRODUCTS
    HOFFMAN, M
    PRATT, CW
    CORBIN, LW
    CHURCH, FC
    JOURNAL OF LEUKOCYTE BIOLOGY, 1990, 48 (02) : 156 - 162
  • [22] MODULATION OF HEPARIN COFACTOR-II ACTIVITY BY GLYCOSAMINOGLYCANS AND ADHESIVE GLYCOPROTEINS
    PETZELBAUER, E
    SEIFFERT, D
    BECKMANN, R
    PUSCH, B
    GEIGER, M
    BINDER, BR
    THROMBOSIS RESEARCH, 1992, 66 (05) : 559 - 567
  • [23] ANTITHROMBOTIC ACTIVITY OF RECOMBINANT TICK ANTICOAGULANT PEPTIDE AND HEPARIN IN A RABBIT MODEL OF VENOUS THROMBOSIS
    FIORAVANTI, C
    BURKHOLDER, D
    FRANCIS, B
    SIEGL, PKS
    GIBSON, RE
    THROMBOSIS RESEARCH, 1993, 71 (04) : 317 - 324
  • [24] Age-related differences in heparin cofactor antigen and activity in healthy children: evidence for structural differences in heparin cofactor II in neonates
    Summerhayes, R. G.
    Monagle, P.
    Ignjatovic, V
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 181 - 181
  • [25] Dermatan sulfate is the predominant antithrombotic glycosaminoglycan in vessel walls: Implications for a possible physiological function of heparin cofactor II
    Tovar, AMF
    de Mattos, DA
    Stelling, MP
    Sarcinelli-Luz, BSL
    Nazareth, RA
    Mourao, PAS
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2005, 1740 (01): : 45 - 53
  • [26] Recombinant dermatan sulfate is a potent activator of heparin cofactor II-dependent inhibition of thrombin
    Tykesson, Emil
    Maccarana, Marco
    Thorsson, Hanna
    Liu, Jian
    Malmstrom, Anders
    Ellervik, Ulf
    Westergren-Thorsson, Gunilla
    GLYCOBIOLOGY, 2019, 29 (06) : 446 - 451
  • [27] Placental dermatan sulfate: isolation, anticoagulant activity, and association with heparin cofactor II
    Giri, TK
    Tollefsen, DM
    BLOOD, 2006, 107 (07) : 2753 - 2758
  • [28] EVIDENCE FOR A REDUCED HEPARIN COFACTOR-II BIOLOGICAL-ACTIVITY IN DIABETES
    CERIELLO, A
    QUATRARO, A
    DELLORUSSO, P
    MARCHI, E
    MILANI, MR
    GIUGLIANO, D
    HAEMOSTASIS, 1990, 20 (06) : 357 - 361
  • [29] Heparin promotes proteolytic inactivation by thrombin of a reactive site mutant (L444R) of recombinant heparin cofactor II
    Ciaccia, AV
    Willemze, AJ
    Church, FC
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (02) : 888 - 893
  • [30] FLURBINITROXYBUTYLESTER - A NOVEL ANTIINFLAMMATORY DRUG HAS ENHANCED ANTITHROMBOTIC ACTIVITY
    CIRINO, G
    CICALA, C
    MANCUSO, F
    BAYDOUN, AR
    WALLACE, JL
    THROMBOSIS RESEARCH, 1995, 79 (01) : 73 - 81
12345